RELOXALIASE
UNII 48OB405WWC

Substance Identification & Data

This profile provides standardized clinical and technical data for Reloxaliase, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 48OB405WWC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 202011-67-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

48OB405WWC

CAS Registry Number

202011-67-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

RELOXALIASE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C152180

National Cancer Institute reference terminology for clinical and research data.

INN ID

10493

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Reloxaliase. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.